{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:53:51Z","timestamp":1790823231267,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.psychres.2018.04.005","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T12:03:26Z","timestamp":1523361806000},"page":"56-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern study"],"prefix":"10.1016","volume":"267","author":[{"given":"Josep Maria","family":"Haro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Altamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helio","family":"Elkis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3171-640X","authenticated-orcid":false,"given":"Jonathan","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Odile","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Zink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Malla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1019-5468","authenticated-orcid":false,"given":"Corrado","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8196-460X","authenticated-orcid":false,"given":"Justine","family":"Lalonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lena","family":"Nordstroem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2018.04.005_bib0001","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1176\/appi.ajp.2013.12030315","article-title":"Meta-regression analysis of placebo response in antipsychotic trials, 1970\u20132010","volume":"170","author":"Agid","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2018.04.005_bib0002","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2000"},{"key":"10.1016\/j.psychres.2018.04.005_bib0003","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.psychres.2018.04.005_bib0004","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/schbul\/sbl057","article-title":"Persistent negative symptoms in schizophrenia: an overview","volume":"33","author":"Buchanan","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2018.04.005_bib0005","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/schbul\/sbp007","article-title":"Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years","volume":"36","author":"Cassidy","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2018.04.005_bib0006","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1176\/ps.2006.57.8.1094","article-title":"Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial","volume":"57","author":"Chakos","year":"2006","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psychres.2018.04.005_bib0007","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.schres.2011.09.006","article-title":"Persistent negative symptoms in first-episode schizophrenia: a prospective three-year follow-up study","volume":"133","author":"Chang","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2018.04.005_bib0008","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2147\/NDT.S43404","article-title":"Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment options","volume":"10","author":"Chue","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.psychres.2018.04.005_bib0009","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2165\/00023210-200216070-00004","article-title":"Relapse and rehospitalisation rates in patients with schizophrenia","volume":"16","author":"Csernansky","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2018.04.005_bib0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/oxfordjournals.schbul.a033316","article-title":"Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorder","volume":"24","author":"Doering","year":"1998","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2018.04.005_bib0011","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/eb-2015-102098","article-title":"Increasing placebo response in antipsychotic trials: a clinical perspective","volume":"18","author":"Dold","year":"2015","journal-title":"Evid. Based Ment. Health"},{"key":"10.1016\/j.psychres.2018.04.005_bib0012","first-page":"114","article-title":"The concepts of remission and recovery in schizophrenia","volume":"24","author":"Emsley","year":"2011","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.psychres.2018.04.005_bib0013","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.euroneuro.2014.03.001","article-title":"Effect of antipsychotic medication on overall life satisfaction among individuals with chronic schizophrenia: findings from the NIMH CATIE study","volume":"24","author":"Fervaha","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2018.04.005_bib0014","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/acps.12289","article-title":"Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia","volume":"130","author":"Fervaha","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2018.04.005_bib0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5498\/wjp.v5.i2.167","article-title":"What is schizophrenia? 25 years of research into schizophrenia - the age beginning course study","volume":"5","author":"H\u00e4fner","year":"2015","journal-title":"World J. Psychiatry."},{"key":"10.1016\/j.psychres.2018.04.005_bib0016","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.schres.2015.09.001","article-title":"Understanding the impact of persistent symptoms in schizophrenia: Cross-sectional findings from the Pattern study","volume":"169","author":"Haro","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2018.04.005_bib0017","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/01.jcp.0000246215.49271.b8","article-title":"Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study","volume":"26","author":"Haro","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"issue":"Suppl. 107","key":"10.1016\/j.psychres.2018.04.005_bib0018","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1034\/j.1600-0447.107.s416.4.x","article-title":"The European Schizophrenia Outpatient Health Outcomes Study: baseline findings across country and treatment","author":"Haro","year":"2003","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2018.04.005_bib0019","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1034\/j.1600-0447.2003.00064.x","article-title":"The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment","volume":"107","author":"Haro","year":"2003","journal-title":"Acta Psychiatr. Scand."},{"issue":"Suppl. 416","key":"10.1016\/j.psychres.2018.04.005_bib0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1600-0447.107.s416.5.x","article-title":"The clinical global impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia","author":"Haro","year":"2003","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2018.04.005_bib0021","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/schbul\/sbi026","article-title":"Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study","volume":"31","author":"Harrow","year":"2005","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2018.04.005_bib0022","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1176\/ajp.151.10.1409","article-title":"One hundred years of schizophrenia: a meta-analysis of the outcome literature","volume":"151","author":"Hegarty","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2018.04.005_bib0023","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-0447.1994.tb08093.x","article-title":"Age and other factors relevant to the rehospitalization of schizophrenic outpatients","volume":"89","author":"Hoffman","year":"1994","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2018.04.005_bib0024","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pnpbp.2015.08.010","article-title":"Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones","volume":"65","author":"Iasevoli","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2018.04.005_bib0025","article-title":"Twenty years of schizophrenia research in the Northern Finland Birth Cohort 1966: a systematic review","volume":"2015","author":"Jaaskelainen","year":"2015","journal-title":"Schizophr. Res. Treat."},{"key":"10.1016\/j.psychres.2018.04.005_bib0026","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.4088\/JCP.13m08606","article-title":"The relative contribution of cognition and symptomatic remission to functional outcome following treatment of a first episode of psychosis","volume":"75","author":"Jordan","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2018.04.005_bib0027","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2018.04.005_bib0028","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/S0033291700012976","article-title":"Schizophrenic syndromes, cognitive performance and neurological dysfunction","volume":"17","author":"Liddle","year":"1987","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2018.04.005_bib0029","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0920-9964(93)90049-O","article-title":"Three syndrome concept of schizophrenia. A factor analytic study","volume":"10","author":"Malla","year":"1993","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2018.04.005_bib0030","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4088\/JCP.v58n1205","article-title":"The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials","volume":"58","author":"Marder","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2018.04.005_bib0031","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/epirev\/mxn001","article-title":"Schizophrenia: a concise overview of incidence, prevalence, and mortality","volume":"30","author":"McGrath","year":"2008","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.psychres.2018.04.005_bib0032","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1017\/S0033291706007951","article-title":"A systematic review of longitudinal outcome studies of first-episode psychosis","volume":"36","author":"Menezes","year":"2006","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2018.04.005_bib0033","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1176\/appi.ajp.162.3.495","article-title":"Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up","volume":"162","author":"Milev","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2018.04.005_bib0034","first-page":"323","article-title":"Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning","volume":"101","author":"Morosini","year":"2000","journal-title":"Acta Psychiatr. Scand"},{"key":"10.1016\/j.psychres.2018.04.005_bib0035","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1192\/bjp.179.4.340","article-title":"Duration of untreated psychosis and cognitive functioning in first-episode patients","volume":"179","author":"Norman","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2018.04.005_bib0036","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1176\/ajp.156.3.400","article-title":"Symptoms and cognition as predictors of community functioning: a prospective analysis","volume":"156","author":"Norman","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2018.04.005_bib0037","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.schres.2008.11.007","article-title":"Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study","volume":"108","author":"Novick","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2018.04.005_bib0038","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00213-007-0730-2","article-title":"Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study","volume":"191","author":"Novick","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psychres.2018.04.005_bib0039","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia","volume":"388","author":"Owen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2018.04.005_bib0040","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1176\/ps.46.11.1161","article-title":"Quality of life and clinical predictors of rehospitalization of persons with severe mental illness","volume":"46","author":"Postrado","year":"1995","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psychres.2018.04.005_bib0041","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2012.01.015","article-title":"Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data","volume":"137","author":"Rabinowitz","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2018.04.005_bib0042","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1176\/appi.ajp.161.3.473","article-title":"Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder","volume":"161","author":"Robinson","year":"2004","journal-title":"Am. J. Psychiatry."},{"key":"10.1016\/j.psychres.2018.04.005_bib0043","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpsyc.56.3.241","article-title":"Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder","volume":"56","author":"Robinson","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2018.04.005_bib0044","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/jamapsychiatry.2014.1319","article-title":"Placebo response in antipsychotic clinical trials: a meta-analysis","volume":"71","author":"Rutherford","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2018.04.005_bib0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/13651501.2012.687452","article-title":"Factors associated with relapse in patients with schizophrenia","volume":"17","author":"San","year":"2013","journal-title":"Int. J. Psychiatry. Clin. Pract."},{"key":"10.1016\/j.psychres.2018.04.005_bib0046","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/0929867043456070","article-title":"A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation","volume":"11","author":"Stahl","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.psychres.2018.04.005_bib0047","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/schbul\/sbn167","article-title":"Periods of recovery in deficit syndrome schizophrenia: a 20-year multi\u2013follow-up longitudinal study","volume":"36","author":"Strauss","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2018.04.005_bib0048","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/hup.2421","article-title":"A review on schizophrenia and relapse \u2013 a quest for user-friendly psychopharmacotherapy","volume":"29","author":"Suzuki","year":"2014","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.psychres.2018.04.005_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2012.02.013","article-title":"Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation","volume":"197","author":"Suzuki","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2018.04.005_bib0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.schres.2011.09.016","article-title":"Treatment resistant schizophrenia and response to antipsychotics: a review","volume":"133","author":"Suzuki","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2018.04.005_bib0051","doi-asserted-by":"crossref","unstructured":"Tajima-Pozo, K., de Castro Oller, M.J., Lewczuk, A., Monta\u00f1es-Rada, F., 2015. Understanding the direct and indirect costs of patients with schizophrenia. Version 2. F1000Res. 4, 182.","DOI":"10.12688\/f1000research.6699.1"},{"key":"10.1016\/j.psychres.2018.04.005_bib0052","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol \u2013 a EuroQol-a new facility for the measurement of health-related quality of life","volume":"16","author":"Group","year":"1990","journal-title":"Health Policy"},{"key":"10.1016\/j.psychres.2018.04.005_bib0053","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.schres.2014.10.043","article-title":"Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8 years later","volume":"161","author":"Ventura","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2018.04.005_bib0054","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.schres.2011.06.025","article-title":"Remission and recovery during the first outpatient year of the early course of schizophrenia","volume":"132","author":"Ventura","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2018.04.005_bib0055","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1017\/S003329170800514X","article-title":"Predictors of 10-year outcome of first-episode psychosis","volume":"39","author":"White","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2018.04.005_bib0056","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1192\/bjp.177.1.42","article-title":"Self-report quality of life measure for people with schizophrenia: the SQLS","volume":"177","author":"Wilkinson","year":"2000","journal-title":"Br. J. Psychiatr."},{"key":"10.1016\/j.psychres.2018.04.005_bib0058","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S2215-0366(16)00023-7","article-title":"Schizophrenia treatment: an obstacle course","volume":"3","author":"Zink","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2018.04.005_bib0059","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1586\/17512433.2015.1040393","article-title":"Glutamatergic agents for schizophrenia: current evidence and perspectives","volume":"8","author":"Zink","year":"2015","journal-title":"Expert Rev. Clin. Pharmacol."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178117312453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178117312453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:25:59Z","timestamp":1759037159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178117312453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":58,"alternative-id":["S0165178117312453"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2018.04.005","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern study","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2018.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}